AMBER PAYNE: Open Payments
NPI 1104830686 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 59 payments from 18 companies in 2025. Trend: 2023 $838 · 2024 $1,257 · 2025 $1,179
Food & beverage: $1,134Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $207 |
| Lilly USA, LLC | 10 | $182 |
| PFIZER INC. | 6 | $108 |
| SANOFI-AVENTIS U.S. LLC | 4 | $105 |
| Corcept Therapeutics | 3 | $91 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| ABBVIE INC. | 4 | $65 |
| Astellas Pharma US Inc | 3 | $53 |
| Dexcom, Inc. | 2 | $46 |
Products named: TZIELD, JARDIANCE, MOUNJARO, Korlym, Wegovy, Ozempic, AIRSUPRA, Veozah.
Industry payments across TX — which companies pay providers there.
